[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-574965-105":59,"doc-detail-574965-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ph-sensitive-lipid-polymeric-hybrid-nanoparticle-lphnp-of-paclitaxel-and-curcumin-for-targeted-delivery-in-breast-cancer","pH sensitive lipid polymeric hybrid nanoparticle (LPHNP) of paclitaxel and curcumin for targeted delivery in breast cancer","","Objective: design a pH sensitive lipid polymeric hybrid nanoparticle (LPHNP) for targeted, triggered release of paclitaxel and curcumin in breast cancer. Significance: achieve controlled release in the acidic tumor microenvironment, improving pharmacokinetic behavior. Methods: synthesize chitosan-coated curcumin and paclitaxel co-loaded pH-sensitive LPHNPs via nanoprecipitation and characterize size, PDI, zeta potential, and morphology. Results: obtain ~146 nm particles with PDI 0.18 and >90% entrapment; enhanced in vitro and in vivo performance in rats. Conclusions: chitosan-coated LPHNPs support high loading, suitable cellular penetration size, and prolonged circulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ph-sensitive-lipid-polymeric-hybrid-nanoparticle-lphnp-of-paclitaxel-and-curcumin-for-targeted-delivery-in-breast-cancer/574965/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ph-sensitive-lipid-polymeric-hybrid-nanoparticle-lphnp-of-paclitaxel-and-curcumin-for-targeted-delivery-in-breast-cancer/574965.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-10-14",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study?","Question",{"text":112,"@type":113},"To design a pH sensitive lipid polymeric hybrid nanoparticle (LPHNP) that enables targeted, triggered delivery of paclitaxel and curcumin in breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the nanoparticles prepared and evaluated?",{"text":117,"@type":113},"Chitosan-coated curcumin and paclitaxel co-loaded pH-sensitive LPHNPs were synthesized using a nanoprecipitation technique, then characterized by size, PDI, zeta potential, and morphology.",{"name":119,"@type":110,"acceptedAnswer":120},"What improvements were observed in vitro and in vivo?",{"text":121,"@type":113},"In vitro, curcumin and paclitaxel release increased under tumor pH conditions and cytotoxicity improved. In vivo in rats, pharmacokinetic studies showed increased bioavailability, along with prolonged retention and higher half-life.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},574965,1792401147,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Drug Development and  \nIndustrial Pharmacy  \nISSN: 0363-9045 (Print) 1520-5762 (Online) Journal [homepage: ](homepage: www.tandfonline.com/journals/iddi20)[www.tandfonline.com/journals/iddi20](homepage: www.tandfonline.com/journals/iddi20)  \npH sensitive lipid polymeric hybrid nanoparticle (LPHNP) of paclitaxel and curcumin for targeted delivery in breast cancer  \nHrishikesh Sarma, Ankit Dutta, Ala kesh Bharali, Sheikh Soﬁ ur Rahman, Sunayana Baruah, Nikhil Biswas & B hanu P. Sahu  \nTo cite this article: Hrishikesh Sarma, Ankit Dutta, Ala kesh Bharali, Sheikh Soﬁ ur Rahman, Sunayana Baruah, Nikhil Biswas & B hanu P. Sahu (2024) pH sensitive lipid polymeric hybrid nanoparticle ( LPHNP) of paclitaxel and curcumin for targeted delivery in breast cancer, Drug Development and Industrial Pharmacy, 50: 10, 856-864, DOI: 10.1080/03639045.2024.2421198  \nTo link to this article: [https://doi.org/10.1080/03639045.2024.2421](https://doi.org/10.1080/03639045.2024.2421)198  \n View supplementary material   \n\n|  Published online: 03 Nov 2024. |  |\n| --- | --- |\n| | Submit your article to this journal  |\n| | Article views: 301 |\n| | View related articles  |\n|  View Crossmark data |  |\n|  Citing articles: 10 View citing articles  |  |\n\nFull Terms & Conditions of access and use can be found at [https://www.tandfonline.com/action/journalInformation?journalCode=iddi20](https://www.tandfonline.com/action/journalInformation?journalCode=iddi20)  \nDrug Development anD InDustrIal pharmacy 2024, vol. 50, no. 10, 856–864  \n[https://doi.org/10.1080/03639045.2024.2421198](https://doi.org/10.1080/03639045.2024.2421198)  \nReseaRch aRticle  \npH sensitive lipid polymeric hybrid nanoparticle (LPHNP) of paclitaxel and curcumin for targeted delivery in breast cancer  \nhrishikesh sarmaa, ankit Duttaa, alakesh Bharalia,b, sheikh sofiur Rahmana, sunayana Baruahc, Nikhil Biswasa,b and Bhanu P. sahua,b  \napharmaceutics research lab, gIps, assam science and technology university, guwahati, assam, India; badvanced Drug Delivery lab, school of pharmaceutical sciences, girijananda chowdhury university, guwahati, assam, India; canimal house Facility, girijananda chowdhury university, guwahati, assam, India  \nABSTRACT  \nObjective: the study aimed at designing a ph sensitive lipid polymeric hybrid nanoparticle (lPhNP) for targeted release of Paclitaxel (PtX) and curcumin (cUR) in breast cancer.  \nSignificance: such systems shall result in controlled triggered release in acidic microenvironment of tumor cells with improved pharmacokinetic profile.  \nMethods: chitosan-coated cUR and PtX coloaded ph-sensitive lPhNPs were synthesized employing nanoprecipitation technique. the synthesized NPs were characterized in terms of particle size, polydispersity index (PDi), zeta potential, and morphology.  \nResults: lPhNPs co-loaded with curcumin (cUR) and paclitaxel (PtX) were successfully formulated, achieving a size of 146 nm, a PDi of 0.18, and an entrapment efficiency exceeding 90%. In vitro release studies demonstrated controlled release of cUR and PtX under tumor ph conditions showing 1.6 fold and 1.7 fold higher release in aBs ph 5 in comparison to PBs 7.4 for PtX and cUR respectively. Mtt-assay studies revealed enhanced cytotoxicity of cUR and PtX as lPhNPs showing ic50 value of free cUR & PtX 480.06 µg/ ml decreasing to 282.97 µg/ml for cs-cUR-PtX-lPhNPs. In vivo pharmacokinetic evaluations in rats confirmed significantly improved bioavailability, with a 3.8-fold increase in aUc for cUR and a 6.6-fold increase for PtX. additionally, the lPhNPs demonstrated controlled release and prolonged retention, evidenced by a 2.2-fold increase in the half-life (t1/2) of cUR and a 1.3-fold increase in the half-life of PtX. Conclusions: the results underscores potential of chitosan-coated lPhNP as a promising delivery platform, offering high drug loading, optimal size for cellular penetration, and prolonged blood circulation for cancer.  \nARTICLE HISTORY  \nreceived 18 June 2024 revised 8 sept","cbCainmLpxpjvGJh","https://ap.wps.com/l/cbCainmLpxpjvGJh","pdf",4044864,"English","# Abstract\n# Introduction\n# Methods\n## Nanoparticle synthesis and characterization\n# Results\n## In vitro release and cytotoxicity\n## In vivo pharmacokinetics\n# Conclusions\n# Article history\n# Keywords","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To design a pH sensitive lipid polymeric hybrid nanoparticle (LPHNP) that enables targeted, triggered delivery of paclitaxel and curcumin in breast cancer.\"},{\"question\":\"How were the nanoparticles prepared and evaluated?\",\"answer\":\"Chitosan-coated curcumin and paclitaxel co-loaded pH-sensitive LPHNPs were synthesized using a nanoprecipitation technique, then characterized by size, PDI, zeta potential, and morphology.\"},{\"question\":\"What improvements were observed in vitro and in vivo?\",\"answer\":\"In vitro, curcumin and paclitaxel release increased under tumor pH conditions and cytotoxicity improved. In vivo in rats, pharmacokinetic studies showed increased bioavailability, along with prolonged retention and higher half-life.\"}]","pH sensitive lipid polymeric hybrid nanoparticle (LPHNP) of paclitaxel and curcumin for targeted delivery in breast cancer | PDF",1792012378,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-18/6d9d561c766925d20f67ff324302667d.webp",983,1290,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-18/0755910e06df53c930295dce716d2a92.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-18/5135ba81fa4283ac1663a9a1c7afd5c6.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-18/4fd05c5fdc6005e9012bacd026dc35e6.webp",980,1268]